派林生物 (000403)

Pacific Shuanglin Bio-pharmacy Co., LTD

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 95039.74
  • Circulating A-Shares(W): 94071.01
  • Earnings Per Share(RMB): 0.3800
  • Net Assets Per Share(RMB): 8.4448
  • Operating Revenue(W RMB): 161814.65
  • Total Profit(W RMB): 40693.70
  • Net Profit Attributable to Parent(W RMB): 35718.11
  • Net Profit Growth Rate(%): -34.19
  • Weighted Return on Equity(%): 4.4500
  • Operating Cash Flow Per Share(RMB): -0.1020
  • Undistributed Profit Per Share(RMB): 2.4977
  • Capital Reserve Per Share(RMB): 4.7758

2. Main Business

The main business covers:

  • Research, development, production and sales of blood products

3. Company Basic Information

  • Company Name: Pacific Shuanglin Bio-pharmacy Co., Ltd.
  • Listing Date: 1996-06-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1 Xinfeng East Road, Donghai Island, Dongjian Town, Mazhang District, Zhanjiang City, Guangdong Province
  • Website: ---
  • Company Profile:The company was established in 1993 by Jiangxi Yichun Engineering Machinery Factory. It started with its net assets converted into 30.18 million state-owned shares, 9 million privately placed corporate shares, and 1 million employee shares. After the first online pricing issuance on June 7, 1996, the total number of shares at the time of listing was 64.18 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Gongqingcheng Sheng Bang Yinghao Investment Partnership (Limited Partnership) General Legal Person 19987.87 21.25
2 Harbin Tongzhicheng Technology Development Co., Ltd. General Legal Person 10449.55 11.11
3 Shenzhen Shipping Health Technology Co., Ltd. General Legal Person 4187.31 4.45
4 Tibet Zheyan Enterprise Management Co., Ltd. General Legal Person 1923.18 2.04
5 Hengqin Guangjin Meihao Fund Management Co., Ltd. - Meihao Hedwig No. 1 Private Securities Investment Fund Private Securities Investment Fund 1768.00 1.88
6 Harbin Lanxiang Biotechnology Consulting Co., Ltd. General Legal Person 1497.18 1.59
7 National Social Security Fund 406 Portfolio Social Security Fund 1146.61 1.22
8 Tianjin Honghan Technology Co., Ltd. General Legal Person 1053.94 1.12
9 Penghua Anqing Hybrid Securities Investment Fund Class A Fund 19.05 0.02
10 Penghua Zunhui 18-month Regular Open Hybrid Securities Investment Fund Class A Fund 13.85 0.01

5. Concept Sectors

  • Hepatitis Concept
  • Margin Trading & Securities Lending
  • Control Change
  • Heavy Holdings by Private Funds
  • Small-Cap Growth
  • SZSE Growth Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information